
AGA Patient Case: Persistent hepatic encephalopathy
A recent case in the forum involves a patient with cirrhosis and a MELD-Na of 7 who presents for evaluation of uncontrolled hepatic encephalopathy. The current medication regimen includes lactulose titrated to three bowel movements per day, rifaximin 550 mg BID and zinc 220 mg BID. The patient continues to report symptoms of forgetfulness and […]